Discovery via Rediscovering India” series, with its latest exhibition—Part IV—signifying the beta introduction of this ...

IRPC Public Company Limited (IRPC) is set to launch and offer bonds and digital bonds to general investors through ten financial institutions, with projected stable interest rates ranging from 3.70% ...

Bestselling author Veronica Roth, the creator of the Divergent franchise, reflects on the book series' most divisive character death in a funny way.

1 Department of Chemistry and Research Centre, Scott Christian College (Autonomous), Nagercoil, Tamilnadu, India 2 Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology ...

Having shown last week that its opioid alternative can reduce post-surgery pain, Tris Pharma is back with another slice of clinical data to show that the drug is less likely to be abused.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve got lots of news coming out of D.C. today ...

Tris Pharma has reported positive topline outcomes from its ALLEVIATE-1 Phase III trial of cebranopadol for treating moderate-to-severe acute pain in individuals post-abdominoplasty surgery.

Top of the morning to you, and a fine one it is, although we confess it is a bit frigid here on the Pharmalot campus. Even the official mascots are spending less time foraging for breakfast.

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The designation ...